Chondroitin Sulfates: Clinical Trials

26 trials of Chondroitin Sulfates, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 4 withdrawn, 2 unknown, 1 recruiting. 8 Phase 3, 6 Not applicable, 4 Phase 1, 4 Phase 4, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 5, Withdrawn 2, Unknown 1
Not applicable6Completed 5, Recruiting 1
Phase 14Completed 2, Withdrawn 2
Phase 44Completed 3, Unknown 1
Phase 23Completed 2, Withdrawn 1

Follow Chondroitin Sulfates: new trials by email Literature Review of Chondroitin Sulfates trials Research Report on Chondroitin Sulfates

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early vs Delayed Intravesical Blad-Care During BCG Therapy
Hyaluronic Acid and Chondroitin Sulfate (Blad-Care™) - Urinary Bladder Neoplasms, BCG-Induced Cystitis
Not applicableRecruitingBLAD-HYA Group562025-11-032026-03-27
Phase I Clinical Study of Chondroitin Sulfate for Treatment of NEC
Chondroitin sulfate - Necrotizing Enterocolitis, Intestinal Ischemia
Phase 1WithdrawnIndiana University2025-01-012025-10-10
TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study
Chondroitin Sulfate Sodium, Placebo - Knee Osteoarthritis
Phase 3WithdrawnIBSA Institut Biochimique SA2023-12-012023-10-05
Study on Structum® in Adult Patients With Osteoarthritis (TRUST)
Chondroitin sulfate - Osteoarthritis, Knee
CompletedPierre Fabre Medicament1362023-07-122026-09-08
To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee
Collavant n2 40 mg/day, Glucosamine hydrochloride & Chondroitin sulfate, Microcrystalline cellulose - Osteoarthritis, Knee
Not applicableCompletedVedic Lifesciences Pvt. Ltd.2362022-08-082023-09-06
Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate, Triamcinolone Acetonide alone - Macula Edema
Not applicableCompletedAl-Azhar University782020-01-022022-05-26
Effects of Glucosamine and Chondroitin Sulfate Supplementation in Addition to Resistance Exercise Training and Manual Therapy in Patients With Knee Osteoarthritis
Chondroitin Sulfate, Resistance exercise training, Manual therapy / Joint Mobilization - Osteoarthritis, Osteoarthritis, Knee
Not applicableCompletedFoundation University Islamabad242020-01-012020-12-04
"Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy"
Standard Postoperative Rehabilitation Protocol, Oral Chondroitin Sulfate (Flextrum), ntra-articular Hyaluronic Acid Injection (Biolevox) - Meniscus Lesion, Knee Injuries
Not applicableCompletedCollegium Medicum w Bydgoszczy2902019-10-102026-03-17
A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
glucosamine sulphate 1500mg and meloxicam 15mg, Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg, Placebos - Knee Osteoarthritis
Phase 3WithdrawnEurofarma Laboratorios S.A.2019-01-012022-04-18
Glucosamine and Chondroitin in Gut in Preventing People From Inflammation
Glucosamine Sulfate/Chondroitin Sulfate Tablet, Placebo - Healthy Subject
Phase 1CompletedFred Hutchinson Cancer Center92018-05-112019-05-24
The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients
Hyaluronic Acid and Chondroitin Sulfate - Interstitial Cystitis
Not applicableCompletedSamsung Medical Center622017-09-222022-10-27
Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects
PRO-087, Systane Ultra, Xyel Ofteno - Dry Eye Syndromes, Lubricant Allergy
Phase 1CompletedLaboratorios Sophia S.A de C.V.302017-07-172019-07-19
Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
PRO-087, Systane Ultra, Systane Ultra Preservative Free - Dry Eye Syndrome
Phase 4CompletedLaboratorios Sophia S.A de C.V.3262016-10-132019-10-31
Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA
chondroitin sulfate, celecoxib, placebo - Knee Osteoarthritis
Phase 3CompletedIBSA Institut Biochimique SA6042014-06-122017-03-03
Study With Chondroitin Sulfate and Glucosamine Sulfate (in Dosage Capsule and Sachet) in Treating Osteoarthritis
Chondroitin sulfate + Glucosamine sulfate - Osteoarthritis
Phase 3UnknownAzidus Brasil3202011-11-012011-02-10
Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis
Chondroitin/Glucosamine (Droglican), Celecoxib - Knee Osteoarthritis
Phase 4CompletedBioiberica6062011-09-012016-02-26
Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI
Chondroitin sulfate, Celecoxib - Knee Osteoarthritis
Phase 3CompletedBioiberica1942011-06-012016-08-19
Life 4°C Versus Optisol in Corneal Storage Media
Corneal donor storage in Optisol GS media solution, Life 4°C solution for cornea storage - Complications of Corneal Transplant
Phase 3CompletedUniversity Hospitals Cleveland Medical Center642011-06-012022-04-18
Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.
Chondroitin sulfate, Placebo - Rhizarthrosis
Phase 4UnknownJuan A. Arnaiz1082011-03-012013-02-22
Chondroitin Sulfate for Crohn's Disease
chondroitin sulfate - Crohn's Disease
Phase 1 / Phase 2WithdrawnUniversity Hospitals Cleveland Medical Center2011-01-012012-08-31

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Osteoarthritis, Knee (10)  ·  Osteoarthritis (4)  ·  Cystitis, Interstitial (3)  ·  Dry Eye Syndromes (2)  ·  Arthralgia (1)  ·  Breast Neoplasms (1)  ·  Crohn Disease (1)  ·  Enterocolitis, Necrotizing (1)  ·  Knee Injuries (1)  ·  Low Back Pain (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Pain (1)  ·  Urinary Bladder Neoplasms (1)

Sponsors

Bioiberica (2)  ·  IBSA Institut Biochimique SA (2)  ·  Laboratorios Sophia S.A de C.V. (2)  ·  University Hospitals Cleveland Medical Center (2)  ·  Ache Laboratorios Farmaceuticos S.A. (1)  ·  Al-Azhar University (1)  ·  Ardabil University of Medical Sciences (1)  ·  Azidus Brasil (1)  ·  BLAD-HYA Group (1)  ·  Collegium Medicum w Bydgoszczy (1)  ·  Dawn L. Hershman (1)  ·  Eurofarma Laboratorios S.A. (1)  ·  Foundation University Islamabad (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Indiana University (1)

Countries

United States (7)  ·  Poland (3)  ·  Mexico (2)  ·  South Korea (2)  ·  Spain (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Egypt (1)  ·  India (1)  ·  Iran (1)  ·  Italy (1)  ·  Pakistan (1)  ·  Russia (1)

Top investigators

Chunwoo Lee (1)  ·  Dawn Hershman, MD (1)  ·  Dr Shalini Srivastava, MD medicine (1)  ·  Gurkirpal Singh, MD (1)  ·  Jean-Pierre Pelletier, MD (1)  ·  Jean-Yves Reginster, Prof. MD PhD (1)  ·  Joanna Lampe (1)  ·  Jonathan Lass, M.D. (1)  ·  Jordi Monfort, MD (1)  ·  Lawrence A Hill, PharmD, MBA (1)  ·  Leopoldo Baiza, MD (1)

Results publications

PMID 16495392, PMID 18821708, PMID 25589511, PMID 25625366, PMID 27809891, PMID 28728606, PMID 34707360, PMID 36156542